News & Press Releases
Check the latest Sapio news and announcements.
Sapio Sciences and Cognizant Life Sciences Manufacturing Partner to Accelerate Digital Lab Transformation in Life Sciences
Collaboration brings together advanced lab informatics and global manufacturing digitalization expertise to support pharma, biotech, and CDMO clients
BALTIMORE, MD, July 24, 2025 — Sapio Sciences, the science-awareTM lab informatics platform, today announced a new strategic partnership with Cognizant Life Sciences Manufacturing, designed to advance lab modernization efforts for life sciences organizations around the world. Together, the two companies will help clients accelerate digital transformation across R&D and manufacturing quality control labs by delivering cloud-enabled, scalable lab solutions that unify LIMS, ELN, and scientific data management.
This partnership brings together Sapio’s powerful, AI-native platform with Cognizant’s global delivery expertise and deep experience implementing lab and manufacturing technologies. The result is a more streamlined, data-driven approach to lab digitalization—supporting smarter, more efficient lab environments that can scale with scientific and compliance demands.
“This partnership combines a powerful and configurable platform from Sapio Sciences with Cognizant’s deep implementation expertise—enabling clients to accelerate lab digitalization, improve ROI, and unlock faster, AI-driven insights that drive smarter, more efficient lab environments,” said Venkatesan Kannan, Lab Automation Lead, Cognizant Life Sciences Manufacturing.
“Cognizant brings the scale and expertise to help Sapio deliver lab digitalization at speed and at scale,” said Andrew Wyatt, Chief Growth Officer at Sapio Sciences. “Together, we’re enabling life sciences organizations to transform faster and smarter with a unified, cloud-native platform.”
The collaboration reflects the companies’ shared commitment to driving the future of lab informatics and data-driven discovery through innovative technology and domain-focused consulting.
About Sapio Sciences
At Sapio Sciences, our mission is to improve lives by accelerating the entire drug lifecycle. Our cloud-based solutions—LIMS, ELN, and Scientific Data Cloud—are unified on a flexible, configurable, and AI-native informatics platform, streamlining complex workflows, unifying scientific data, and enabling faster, smarter decisions across biopharma research and development, clinical diagnostics, and manufacturing.
Trusted by global leaders and innovators worldwide, we support a wide range of best-in-class applications, from NGS and bioanalysis to bioprocessing, stability studies, histopathology, antibody discovery, and in vivo studies.
Discover how Sapio Sciences can revolutionize your lab operations at www.sapiosciences.com and follow us on LinkedIn.
About Cognizant Life Sciences Manufacturing
Cognizant Life Sciences Manufacturing provides end-to-end digital transformation solutions to the life sciences industry, supporting clients’ Manufacturing 4.0 initiatives and improving patient outcomes. Cognizant delivers specialized services in automation, MES, data infrastructure, lab processes, and digital technologies to optimize manufacturing. With over 30,000 life sciences professionals across 100+ global delivery centers in 37 countries—and partnerships with all top 30 pharma and 22 of the top 25 biotech firms—Cognizant is a trusted partner across all IT and OT systems, from conception to completion.
Learn more at www.cognizant.com/pharmamanufacturing.
Media Inquiries
Tim Brook, Sapio Sciences
+44 (0)7760 766213
FAQ
Q: What is the core purpose of the partnership between Sapio Sciences and Cognizant Life Sciences Manufacturing?
A: The partnership aims to accelerate digital lab transformation for life sciences organizations globally by combining Sapio’s advanced AI-native lab informatics platform (LIMS, ELN, Scientific Data Cloud) with Cognizant’s extensive global expertise in digital technologies, lab automation, and enterprise-scale implementation. This helps clients achieve Manufacturing 4.0 initiatives and optimize R&D and quality control operations worldwide.
Q: What specific regions or markets will this partnership primarily serve?
A: This partnership will serve life sciences organizations across key global hubs, with a strong focus on North America (e.g., Boston, San Francisco), Europe (e.g., UK, Germany, Switzerland), and Asia-Pacific (e.g., India, China, Japan). Both companies have established presences and deep client relationships in these critical regions.
Q: How does this collaboration benefit pharmaceutical and biotech companies in terms of geographic reach and compliance?
A: The collaboration offers unparalleled global reach through Cognizant’s 100+ global delivery centers in 37 countries, combined with Sapio’s cloud-based solutions accessible worldwide. This ensures localized support and implementation while helping clients meet diverse regional regulatory compliance requirements, such as FDA regulations in the US and EMA guidelines in Europe.
Q: What types of labs and manufacturing facilities will benefit most from these integrated solutions?
A: The integrated solutions are designed to benefit a wide range of facilities, including pharmaceutical R&D labs, biotech discovery centers, clinical diagnostics labs, and CDMO manufacturing sites. This includes facilities of all sizes, from large multinational corporations to emerging biotechs, operating in any global life sciences cluster.
Q: Can this partnership support organizations looking to expand their operations into new global markets?
A: Yes, absolutely. With Cognizant’s global implementation capabilities and Sapio’s scalable cloud platform, the partnership is ideally positioned to support organizations in expanding their digital lab infrastructure and Manufacturing 4.0 initiatives into new geographic territories, providing expert guidance on local regulations and operational best practices.
Q: What specific technologies are central to the Sapio Platform and how do they aid global digital transformation?
A: The Sapio Platform unifies LIMS (Laboratory Information Management System), ELN (Electronic Lab Notebook), and a Scientific Data Cloud into a single, AI-native solution. These technologies facilitate seamless data flow, automate workflows, and enable data-driven decision-making, which are crucial for consistent and efficient lab operations across globally distributed sites.
Q: How does Cognizant’s global footprint enhance the delivery of Sapio’s solutions?
A: Cognizant’s extensive global footprint, including over 30,000 life sciences professionals and numerous delivery centers, provides localized implementation expertise, on-the-ground support, and a deep understanding of regional market nuances and regulatory landscapes, which is essential for successful, scalable deployments of Sapio’s advanced lab informatics solutions worldwide.